Status:
UNKNOWN
Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics
Lead Sponsor:
Corewell Health West
Conditions:
Lumbar Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Determine the effect of Vancomycin Powder added to the surgical wound at closure on surgical infection rates.
Detailed Description
Study will be blinded and randomized 1:1 to either Vancomycin Powder at closure or no vancomycin powder at closure.
Eligibility Criteria
Inclusion
- All adult, 18 years or greater undergoing posterior approach spinal surgery
Exclusion
- Prisoner, pregnant women, patient under the age of 18, those of diminished decision making capacity.
- patients with known reaction to Vancomycin.
- patients having surgery specifically for spine infection
- patients having ADCF or ALIF
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2016
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT02299882
Start Date
August 1 2012
End Date
January 1 2016
Last Update
November 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spectrum Health Hospitals
Grand Rapids, Michigan, United States, 49503